Abstract Nicorandil is a nitric oxide (NO) donor used in the treatment of angina symptoms. It has also been reported to protect cells and affect the proliferation and death of cells in some tissues. The molecules that interfere with these processes can cause dysfunction in healthy tissues but can also assist in the therapy of some disorders. In this study we examined the effect of nicorandil and of the molecular precursor that does not have the NO radical (N-(beta-hydroxyethyl) nicotinamide) on the cell proliferation and death of human renal carcinoma cells (786-O) under normal oxygenation conditions. The molecular precursor was used in order to analyze the effects independents of NO. In the cytotoxicity test, nicorandil was shown to be cytotoxic at very high concentrations and it was more cytotoxic than its precursor (cytotoxic at concentrations of 2,000 and 3,000 lg/mL, respectively). We propose that the lower cytotoxicity of the precursor is due to the absence of the NO radical. In this study, the cells exposed to nicorandil showed Cytotechnology (2013) 65:839-850 DOI 10.1007 neither statistically significant changes in cell proliferation nor increases in apoptosis or genotoxicity. The precursor generated similar results to those of nicorandil. We conclude that nicorandil causes no changes in the proliferation or apoptosis of the cell 786-O in normal oxygenation conditions. Moreover, the lack of NO radical in the precursor molecule did not show a different result, except in the cell cytotoxicity.
Abstract Nicorandil is a nitric oxide (NO) donor used in the treatment of angina symptoms. It has also been reported to protect cells and affect the proliferation and death of cells in some tissues. The molecules that interfere with these processes can cause dysfunction in healthy tissues but can also assist in the therapy of some disorders. In this study we examined the effect of nicorandil and of the molecular precursor that does not have the NO radical (N-(beta-hydroxyethyl) nicotinamide) on the cell proliferation and death of human renal carcinoma cells (786-O) under normal oxygenation conditions. The molecular precursor was used in order to analyze the effects independents of NO. In the cytotoxicity test, nicorandil was shown to be cytotoxic at very high concentrations and it was more cytotoxic than its precursor (cytotoxic at concentrations of 2,000 and 3,000 lg/mL, respectively). We propose that the lower cytotoxicity of the precursor is due to the absence of the NO radical. In this study, the cells exposed to nicorandil showed Introduction Nicorandil (N-(beta-hydroxyethyl) nicotinamide nitrate ester) belongs to the organic nitrates group (RONO 2 ) which includes nitroglycerin (TNG). It is used in the treatment of cardiac dysfunction and symptoms of angina pectoris. Nicorandil has two important characteristics: it is a nitric oxide (NO) donor and an ATPsensitive potassium (K ATP ) channel activator (Barreto and Correia 2005; Hiremath et al. 2010; Simpson and Wellington 2004) . As a potent vasodilator, nicorandil can hyperpolarize the membrane of muscle cells (Frydman 1992) , which allows coronary and peripheral vasodilatation leading to a decrease in the input and output pressure of the blood flow in the heart. Nicorandil has also been shown to produce ischemic preconditioning of the cell, which protects cardiac tissue (Ahmed et al. 2011; Carreira et al. 2008; Eeckhout 2003; Sato et al. 2000) .
Organic nitrates, like nicorandil, release NO from their structures through enzymatic processes, such as those involving glutathione S-transferase (GST), xanthine oxidase (XO) or complex enzymatic cytochrome P450, or non-enzymatic processes by reacting chemically with acids, alkalis and thiols (Chong and Fung 1991; Seth and Fung 1993) . The released NO is a signaling molecule that readily diffuses across the plasma membrane and binds to the soluble enzyme guanylate cyclase (GC), which catalyzes the conversion of intracellular guanosine-5 0 -triphosphate (GTP) to cyclic guanosine-3 0 ,5 0 -monophosphate (cGMP). cGMP, in turn, acts as a second messenger to maintain the tone and motility of the smooth muscle tissue of blood vessels, promoting vasodilatation. cGMP is also involved in several other processes, such as proliferation and cellular differentiation, the homeostasis of fluids and electrolytes, and apoptosis (Krumenacker and Murad 2006; Mujoo et al. 2010) . Various studies analyze the effects of NO on the cell proliferation and death, which depend on its concentration in the microenvironment, cell type, exposure period and various other factors (Yim et al. 1993; Dimmeler and Zeiher 1997; Masri 2010) .
In addition to its effects on vasodilatation, studies have shown that nicorandil inhibits both the cell death of cardiac tissue and the excessive cellular proliferation of renal tissue. The excessive cell proliferation is observed in the kidney of subject affected by cardiac dysfunction. The administration of nicorandil shows improvement of this situation by reducing the cell proliferation (Segawa et al. 2001; Ishii et al. 2007; Jefferson et al. 2008; Sudo et al. 2009 ). Recurring ischemia-reperfusion events lead to changes in mitochondrial function, which triggers apoptosis in cardiac cells. Previous studies have shown that the activation of the K ATP channel by nicorandil inhibits the depolarization of the mitochondrial membrane and the release of cytochrome c into the cytosol, thus inhibiting apoptosis (Akao et al. 2002; Carreira et al. 2008; Lu 2006; Nagata et al. 2003; Sato et al. 2000) . Lu (2006) showed that isolated rat hearts submitted to ischemia-reperfusion when treatments with nicorandil were protected against post-ischemic damage. Akao et al. (2002) observed the inhibition of cytochrome c release in rat cardiomyocytes that were treated with nicorandil and exposed to oxidative stress. Nishikawa et al. (2006) concluded that under hypoxia nicorandil inhibited apoptosis in myocytes via the cGMP signaling pathway and activation of the K ATP channel, which inhibited the release of cytochrome c, and through influencing the activity and expression of proteins involved in apoptosis, such as caspase 3, Bax and Bcl-2. However, some studies like Taimor et al. (2000) shows that even though under hypoxia the apoptosis is inhibited, under normal oxygenation conditions substances that release NO induce apoptosis.
Besides protecting heart tissue against cell death, some studies have shown that nicorandil can inhibit the excessive proliferation of mesangial cells that occurs in some renal disorders which aggravate adverse cardiac conditions (Segawa et al. 2001; Sudo et al. 2009 ). The exact mechanism by which nicorandil functions must still be clarified, but nicorandil can inhibit cell proliferation by decreasing the expression of transforming growth factor b (TGF-b) and plateletderived growth factor (PDGF), possibly via cGMP (Kastrati et al. 2010; Peters et al. 2003; Segawa et al. 2001; Sudo et al. 2009 ). Liou et al. (2011) observed that nicorandil inhibited rat cardiac fibroblast proliferation, with inhibition angiotensin II (Ang II) (cardiac fibroblasts proliferate in response to Ang II), and this effect may involve the activation of K ATP channels.
Nicorandil's capacity to interfere in the processes of cell proliferation and death is interesting for drug research in the therapy of some disorders involving such processes. Thus, the goal of this study was to investigate if the nicorandil can affect the proliferation and death of 786-O cells under normal oxygenation conditions. Also to determine if the lack of radical NO in its molecular precursor is able to produce similar effects.
Materials and methods

Chemicals
Nicorandil (N-(beta-hydroxyethyl) nicotinamide nitrate ester) and its precursor molecule (N-(beta-hydroxyethyl)nicotinamide) used in this study were synthesized from nicotinic acid in the chemistry laboratory of the Universidade Federal de Minas Gerais and provided by Dr. Â ngelo de Fátima. The precursor (N-(beta-hydroxyethyl) nicotinamide) has a similar structure to nicorandil, but it lacks the nitrite radical (-NO 2 ). The molecules were dissolved at 200 mg/mL in dimethyl sulfoxide (DMSO) (Mallinckrodt, St. Luois, MO, USA) and diluted to working concentrations in the culture medium Dulbecco's modified Eagle's medium (DMEM) (Gibco-Life Technologies, Carlsbad, CA, USA). Doxorubicin (Adriblastina Ò , Pharmacia) was used as the positive control for the induction of damage in cytotoxicity (0.5 lg/mL), cell proliferation (0.1 lg/ mL) and genotoxicity (0.1 lg/mL) assays. Camptothecin (Acros Organics-Fisher Scientific Latin America Headquarters, Suwanee, GA, USA) (20 lg/mL) assays was used as the positive control to induce apoptosis.
Cell culture
The cell line used in this study was the human renal carcinoma cell line (786-O), which was kindly provided by Prof. João Ernesto de Carvalho, CPQBA/UNICAMP. The cells were grown in DMEM (Gibco) supplemented with 10 % fetal bovine serum (FBS) (Gibco) at 37°C and 5 % CO 2 .
Cytotoxicity assay A cytotoxicity assay was performed with MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) (Invitrogen-Life Technologies) in accordance with the protocol described by Mosmann (1983) , with some modifications. We seeded 5 9 10 3 cells in 500 lL of DMEM medium with 10 % FBS in each well of a 24-well culture plate. The plate was incubated for 24 h to stabilize the cells. After this incubation, the medium was replaced with fresh medium plus the treatment solution, and the plates were incubated for 24, 48 or 72 h. We tested both molecules at concentrations of 50, 100, 250, 500, 1,000, 1,500, 2,000 and 3,000 lg/mL. Doxorubicin was used at 0.5 lg/mL as a positive control for cytotoxicity, and the negative control was culture medium with 1.5 % DMSO. After the cells were treated for the indicated times, the medium was withdrawn, and serum-free medium containing 0.167 mg/mL MTT salt was added. After 4 h, the supernatant was removed, and the formazan crystal products were diluted in 500 lL DMSO. The absorbance at 550 nm was converted to a percentage to calculate cell survival using the following formula (Huang et al. 2005) :
where A = absorbance average.
Determination of nitric oxide in the cell culture NO was quantified through the detection of nitrate and nitrite, which are the products of its decomposition, using the methods of Griess (1879), with previously published modifications (Panis et al. 2010) . Two 24-well plates were used for the experiment. The first plate, were seeded with 10 4 cells in 300 lL medium with FBS, per well; the second plate, received only medium with FBS. Both plates were incubated for 24 h, and 300 lL medium containing the treatment was added as follows: negative control (0.25 % DMSO); doxorubicin (0.1 lg/mL); 20, 100 or 500 lg/mL nicorandil; and 20, 100, or 500 lg/mL N-(beta-hydroxyethyl) nicotinamide. The treatments were added in duplicate, to wells of each plate (with/ without cells).
After incubation for 1, 12, 24 or 48 h, 60 lL of the supernatant was collected, deproteinized by adding 75 mM ZnSO 4 solution, homogenized, and centrifuged at 10,000 rpm for 2 min at 4°C. Then 70 lL of a 55 mM NaOH solution was added, and the samples were vortexed and centrifuged at 10,000 rpm for 5 min at 4°C. Subsequently, 250 lL of the supernatant was diluted in 50 lL of glycine buffer solution (45 g/L, pH 9.7).
Cadmium granules (stored in 100 mM H 2 SO 4 ) were rinsed in distilled water and maintained for 5 min in a 5 mM CuSO 4 solution in a glycine-NaOH buffer (15 g/L, pH 9.7). Subsequently, the copper-coated cadmium granules were added to the sample and suspended with gentle stirring for 10 min while the nitrate from the sample was converted to nitrite.
After 10 min, the samples were transferred to another tube, and the same volume of Griess reagent (reagent I: 50 mg of N-naphthyl ethylenediamine in 250 mL of distilled water; reagent II: 5 g of sulphanilamide in 500 mL of 5 % phosphoric acid) was added to determine the nitrite concentration, then after 10 min they were centrifuged at 10,000 rpm for 2 min. To determine the absorbance of the samples, 100 lL was transferred from each tube to a 96-well plate.
A calibration curve was prepared from a stock solution of 250 lM NaNO 2 that was serially diluted to a final concentration of 7.8 lM. The absorbance was determined at 550 nm, and the final results are presented as the concentration of nitrite in lM.
Cellular proliferation
The cellular proliferation was measured following each treatment using the cell count values. The counting was performed after treatment for 24, 48, 72 and 96 h. The cells were seeded at a density of 2.6 9 10 4 cells per culture tube (10 cm 2 ), contained 2.6 mL of culture medium with FBS plus the following treatments: negative control (0.25 % DMSO); positive control of inhibition of proliferation (0.1 lg/ mL doxorubicin); 20, 100, or 500 lg/mL nicorandil; and 20, 100, or 500 lg/mL N-(beta-hydroxyethyl) nicotinamide (concentrations determined from MTT assay results). After the appropriate incubation time, a tube from each treatment condition was trypsinized, and the cells were counted in a Neubauer chamber. The same cell suspension was used to measure cell viability with trypan blue staining. The experiment was repeated three times.
Genotoxicity (comet assay)
A total of 5 mL of culture medium with FBS was added to the culture flasks (25 cm 2 ) in which 5 9 10 5 cells were grown for 24 h. The following treatments were then added: negative control (0.25 % 9DMSO); positive control for DNA damage induction (0.1 lg/ mL doxorubicin); nicorandil (20, 100 or 500 lg/mL); and N-(beta-hydroxyethyl) nicotinamide (20, 100 or 500 lg/mL).
The SCGE assay (single-cell gel electrophoresis, also known as the comet assay) allows the evaluation of primary DNA damage; therefore, we evaluated the cells after 3 h of treatment. The assay was performed under alkaline conditions as described by Singh et al. (1988) and according to Tice et al. (2000) . The cells were trypsinized, and 20 lL of the cell suspension was homogenized with 120 lL of 0.5 % LMP agarose (low melting point; Gibco), distributed onto slides pretreated with agarose (Invitrogen) and covered with a coverslip. After 20 min at 4°C, the coverslips were removed, and the slides were placed in a lysis solution (1 mL Triton and 10 mL DMSO in 89 mL lysis buffer stock [14.61 g NaCl, 3.22 g EDTA, 0.12 g Tris, and 89 mL deionized H 2 O], pH 10, adjusted using NaOH) for 60 min at 4°C. After lysis, the slides were placed in an electrophoresis apparatus with an alkaline buffer solution (pH 13) (5 mL EDTA and 30 mL NaOH 10M in 1,000 mL deionized H 2 O). Denaturing was performed for 20 min before electrophoresis was started.
Electrophoresis was performed at pH 13 at 25 V and 300 mA for 20 min. After electrophoresis, the slides were neutralized with a pH 7.5 buffer (48.5 g 0.4 M Tris in 1,000 mL deionized H 2 O, pH 7.5, adjusted using HCl), fixed with ethyl alcohol and stained with ethidium bromide (20 lg/mL).
One hundred cells were examined for each treatment condition under a fluorescence microscope with a 409 objective. The cells were classified on the basis of damage into classes 0-3 based on the length and intensity of the comet tail: class 0, absence of a tail and no visible damage; class 1, tail of a size up to the diameter of the nucleoid and little damage visible; class 2, medium-sized tail (up to 2 times the diameter of the nucleoid) and moderate damage visible; and class 3, long tail (length greater than 2 times the diameter of the nucleoid) with major damage visible (Kobayashi 1995) .
Cell viability was ascertained with trypan blue exclusion staining. A satisfactory viability for the comet assay was considered to be greater than 80 %. The experiment was repeated three times.
Induction of apoptosis
A total of 4.3 9 10 4 cells per well were grown on coverslips in 6-well plates in 3 mL of medium with FBS. After 24 h, the treatments were added to the wells as follows: nicorandil (20, 100 and 500 lg/mL); N-(beta-hydroxyethyl) nicotinamide (20, 100 and 500 lg/mL); 20 lg/mL camptothecin (to induce apoptosis); and 0.25 % DMSO (as a negative control).
After 24 h, the coverslips were collected as described by Rovozzo and Burke (1973) and in accordance with the modifications proposed by Tsuboy et al. (2010) . The coverslips were washed in saline (PBS), fixed in the Carnoy fixative (methanol:glacial acetic acid ratio of 3:1), and hydrated in a gradual series of alcohol washes (95-25 %). The slides were then transferred to McIlvaine buffer (0.1 M citric acid [1.92 g citric acid in 100 mL 25 % methanol] and 0.2 M disodium phosphate [2.84 g dibasic sodium phosphate in 100 mL 25 % methanol]) for 5 min, transferred to 0.01 % acridine orange (diluted in McIlvaine buffer) for 5 min and then transferred again into McIlvaine buffer for 5 min. The coverslips were placed on a slide and sealed with enamel. The morphological characteristics of a cell that was considered to have undergone apoptosis were a nucleus with condensed chromatin and apoptotic bodies. The characteristic of a normal cell was an intact and uniform nucleus. We analyzed 500 cells for each treatment condition using a fluorescence microscope with a 409 objective.
Real-time RT-PCR (gene expression)
We assessed the gene expression of four protein: caspase 8, protein initiator of the extrinsic pathway of apoptosis (CASP 8); caspase 9, initiator of the intrinsic pathway of apoptosis (CASP 9); survivin, protein inhibitor of caspase (BIRC5); mitochondrial transmembrane protein, anti-apoptotic (BCL-XL).
Real-time RT-PCR was performed according to the MIQE guidelines (Bustin et al. 2009 ). First, 5 9 10 5 cells were grown in 25 cm 2 flasks with 5 mL of DMEM containing 10 % FBS. After 24 h, the following treatments were added: 0.25 % DMSO (negative control), 500 lg/mL nicorandil or 500 lg/mL N-(beta-hydroxyethyl) nicotinamide.
After 12 h of treatment, the cells were trypsinized, and the total RNA was extracted using the TRIzol-LS reagent (Invitrogen) in accordance with the manufacturer's instructions. After the extraction, the RNA was resuspended in 30 lL DEPC water, treated with 0.3 lL DNase I (Invitrogen) and kept on ice. The total RNA extracted from the samples was quantified using a spectrophotometer. Samples with an A260/A280 value between 1.9 and 2.1 were used for the experiment. The integrity of the RNA was confirmed using a 0.8 % agarose gel.
The cDNA was synthesized using 2 lL RNA (1 lg), 2 lL 2.5 lM dNTPs (Invitrogen), 1 lL 10 pM oligo-dT (Invitrogen) and 9.9 lL DEPC water (Invitrogen). This mixture (14.9 lL) was incubated at 65°C for 5 min in a thermal cycler (TECHNE Ò TC 412; Bibby Scientific Limited, Stone, U.K.) and then quickly transferred to ice. Subsequently, 4 lL of Mlv 59 buffer (Invitrogen), 0.1 lL ribonuclease inhibitor (RNase Out, Invitrogen) and 1 lL reverse transcriptase (M-Mlv-RT, Invitrogen) were added. To complete the reaction, the samples (20 lL) were incubated at 37°C in a thermal cycler for 50 min followed by incubation at 70°C for 15 min. The resulting cDNA was stored in a -80°C freezer.
The real-time PCR was performed using a PTC 200 DNA Engine Cycler (MJ Research, BioRad, Hercules, CA, USA) with SYBR Green dye (Platinum SYBR Green, Invitrogen). After the initial denaturation step (50°C for 2 min and 95°C for 3 min), 39 rounds of a 3-step cycle (denaturation at 95°C for 20 s, annealing at 60°C for 30 s and extension at 72°C for 20 s) were performed. The reaction was terminated with an incubation step of 95°C for 10 s and another at 40°C for 1 min. At the end of the reaction, a melting curve was generated from 50 to 95°C, with an increase of 0.5°C every 5 s. The reference gene was GAPDH (glyceraldehyde 3-phosphate dehydrogenase). The experiment was repeated three times. The sequences of the oligonucleotide primers are shown in Table 1 .
Statistics
The data obtained in the study were analyzed using the GraphPad InStat statistical program. A value of p \ 0.05 was accepted as significant for the cytotoxicity, cell proliferation, apoptosis induction and genotoxicity tests using an ANOVA followed by the Dunnett test to compare the treatments with the control. The NO concentration was analyzed using an ANOVA followed by Tukey's test. The gene expression levels were determined as in Pfaffl (2001) , and the statistical analysis was performed using REST-384 software (Pfaffl et al. 2002) .
Results
Cytotoxicity assay
The MTT assay results showed that nicorandil started to be cytotoxic at 2,000 lg/mL (57 % after 24 h). The 1,000 lg/mL concentration induced a slight decrease in viability (81 % after 24 h), but the decrease was not statistically significant. N-(beta-hydroxyethyl) nicotinamide was only cytotoxic at the highest concentration tested, 3,000 lg/mL, at all three treatment times (24, 48 and 72 h), the average reduction in cell viability at these concentrations was 60 %. The cells treated with lower concentrations showed cell viability similar to that of the control (Fig. 1) .
Determination of nitric oxide in the cell culture
The evaluation of NO concentrations showed that the treatment with nicorandil resulted in an increase in the NO concentration in the culture medium compared with the control. The treatment with 500 lg/mL nicorandil induced a statistically significant difference in NO concentration for all of the treatment times (1, 12, 24 and 48 h), with a concentration up to eight times higher than that of the control (325.8 vs. 42.4 lM, respectively; p = 0.0053). The treatment with N-(beta-hydroxyethyl) nicotinamide did not result in a significantly increased or decreased concentration of NO, the values were similar to that of control. Figure 2 shows the average NO concentration generated for each treatment condition.
Cell proliferation
Compared with the control, there was no statistically significant difference in the proliferation of 786-O cells treated with nicorandil or N-(beta-hydroxyethyl) nicotinamide at any of the concentrations tested. Trypan blue staining revealed no decrease in cell viability in response to any of the treatments (cell viabilities over 90 %). The proliferation curve is shown in Fig. 3 . The expression levels of the four genes evaluated (CASP8, CASP9, BRIC5 e BCL XL) in cells treated with nicorandil or N-(beta-hydroxyethyl) nicotinamide were unchanged compared to the control.
Discussion
At low concentrations NO functions as a signaling molecule in normal physiology. An increased synthesis of NO is associated with physiopathological conditions, such as degenerative neural diseases (e.g., Parkinson's and Alzheimer's) or infection and inflammation (Dimmeler and Zeiher 1997) . The beneficial effect of nicorandil on angina symptoms is due to the release of NO from the structure of the drug. According to the literature, nicorandil can affect cellular proliferation and apoptosis in tissues exposed to hypoxia, an effect that can be attributed to the ability of nicorandil to activate mitochondrial K ATP channels and cGMP-dependent mechanisms (Sato et al. 2000; Serizawa et al. 2011) . In this study we analyzed nicorandil's capacity to interfere in the processes of cell proliferation and death in cultures under normal oxygenation conditions, in addition, we observed the effect of the structure independent of NO radical. The structural difference between the nicorandil and N-(beta-hydroxyethyl) nicotinamide is the presence of the radical NO 2 . Therefore only nicorandil released NO into the culture and the effects observed by the treatment with N-(beta-hydroxyethyl) nicotinamide are independent of NO. In agreement with this, our experiments showed that only the cultures that received nicorandil had NO concentrations higher than the control. We observed that after treatment with 500 lg/mL of nicorandil the concentration of NO in the culture medium was eight times higher than the NO concentration in the control, whereas in the culture treated with 500 lg/mL of N-(beta-hydroxyethyl) nicotinamide neither significantly increased or decreased concentration of NO compared to control was observed. This showed that the N-(beta-hydroxyethyl) nicotinamide besides not releasing NO also does not change the synthesis of NO.
In order to verify the cytotoxicity of the two molecules, we evaluated various concentrations by MTT assay. The 786-O renal cell exhibited reduced cell viability only when exposed to 2,000 lg/mL nicorandil, which reduced the cell viability to 57 %, and the cytotoxicity of N-(beta-hydroxyethyl) nicotinamide was observed only at the tested concentration extreme (3,000 lg/mL, with a reduction in cell viability to 58 %). The high concentration of the N-(beta-hydroxyethyl) nicotinamide required to achieve toxicity, compared to the nicorandil, is possibly due the absence of the NO radical, therefore, the NO radical in the nicorandil structure makes it relatively more cytotoxic for 786-O cells than its precursor. The chosen concentrations of nicorandil (20, 100 and 500 lg/mL) for other trials, were not cytotoxic for cells, although higher concentrations of NO than in the control had been shown in culture. The sensitivity to NO varies from cell to cell and according to microenvironmental conditions. The unpaired electron of the NO 2 radical reacts readily with oxygen, to become a superoxide radical, or reacts with transition metals, such as iron, cobalt, manganese or copper, the relative importance of enzymes with transition metal-containing groups, such as iron-sulfur (heme), in different cells can influence the sensitivity of each cell type to the NO concentration (Moncada et al. 1991; Wink et al. 1998) . Hwang et al. (2009) exposed two different lineages of neural cells (astrocytes and microglia) to NO (35 lM), although the astrocytes did not show any decrease in cell viability, the microglial cells had a 90 % reduction in viability. In our study, the amount of NO observed after treatment with 20 and 100 lg/ nicorandil was similar to that used by Hwang et al. (2009) , just as astrocytes, the kidney cells exposed to these conditions did not show altered cell viability, the 786-O renal cell only exhibited reduced cell viability when exposed to 2,000 lg/mL nicorandil.
There are no reports regarding the genotoxicity of nicorandil. However, the reported genotoxicity of NO is dependent on its concentration and the microenvironmental conditions. The activity of NO as a genotoxic agent is primarily attributed to indirect reactions, in which NO interacts with other molecules (e.g., a superoxide anion radical) to generate radicals and other molecules (RNOS, such as peroxide, nitrite, and carcinogenic nitrosamines) that are capable of modifying proteins, acting directly on DNA nucleotides and inhibiting the mechanisms necessary for the repair of DNA lesions (Masri 2010; Nguyen et al. 1992) . In this work, the level of DNA damage observed in the cells following exposure to nicorandil or N-(beta-hydroxyethyl) nicotinamide using a comet assay was not statistically significant. Neither nicorandil nor N-(beta-hydroxyethyl) nicotinamide led to DNA damage in 786-O cells, regardless of the presence of NO. Sudo et al. (2009) showed that in rats with glomerulonephritis the excessive proliferation of the cells of the glomerulus was decreased upon treatment with nicorandil (30 mg/kg), via the inhibition of TGFb and PDGF expression. Segawa et al. (2001) observed the same effect in the cultured mesangial cells of rats that were exposed to nicorandil (at concentrations of 1 lM to 1 mM), and in rat cardiac fibroblasts, Liou et al. (2011) observed that nicorandil decreased cell proliferation via a mechanism that involved the activation of K ATP channels. Even though these studies showed that nicorandil inhibits the proliferation of cells involved in renal injuries, in our study both the nicorandil as N-(beta-hydroxyethyl) nicotinamide, showed no statistically significant reduction in the proliferation of 786-O cells, while at the same time it is possible to observe a trend of decreased proliferation in stages after the treatment (Fig. 3) . However, the different models used in these studies (in vivo model, primary culture and permanent cell culture) may explain the divergent results, because different cell types can respond differently to the same stimulus (Moncada et al. 1991) .
The inhibitory effect of nicorandil on apoptosis of cardiac tissue under conditions of hypoxia and oxidative stress, alleviates the damage caused in the tissue, and has been attributed to the release of NO, the activation of mitochondrial K ATP channels, the interruption of the apoptotic signaling cascade by cGMPdependent mechanisms and the inhibition of caspase-3 activity (Ahmed et al. 2011; Carreira et al. 2008; Nagata et al. 2003) . NO may induce cell death through apoptosis and necrosis, depending on the NO concentration and the interaction of NO with the specific cell type. Taimor et al. (2000) showed that in cardiomyocytes under normal oxygenation conditions, the NO released by S-nitroso-N-acetylpenicillamine (SNAP) induced apoptosis, however, under post-ischemic conditions, apoptosis was inhibited, perhaps because the oxygen radicals formed during reoxygenation scavenged the NO. Under the normal oxygenation conditions of our experiments, nicorandil did not induce apoptosis in 786-O cells at any of the concentrations tested. All of the treatments with nicorandil and N-(beta-hydroxyethyl) nicotinamide resulted in similar levels of apoptotic cells compared to the control. In some studies the nicorandil appeared to be involved in preconditioning the cell that leads to overcome the stress and the stimulation of apoptosis, via the activation of K ATP (Nagata et al. 2003) .
In our study, we did not observe any change in the gene expression of the pro-apoptotic genes CASP8 or CASP9, which was in agreement with the morphological analysis of apoptosis induction. These reports, combined with the literature, suggest that different conditions (the amount of NO, oxygenation and cell type) can influence the different effects of nicorandil on apoptosis.
In conclusion, nicorandil and N-(beta-hydroxyethyl) nicotinamide had different cytotoxic effects both at very high concentrations. The difference was likely caused by the presence of NO in nicorandil. The evaluation of other parameters at the non-cytotoxic concentrations tested demonstrated that the two molecules functioned similarly. These results indicated that the chemical structure, regardless of the presence of NO, did not affect the induction of apoptosis or cellular proliferation nor have genotoxic effects in 786-O cells. Apoptosis was not induced following treatment, and contrary to the expected results, we observed no inhibition of cellular proliferation in 786-O cells. Although it already had been demonstrated that the treatment with nicorandil can influence the cell proliferation and death in cardiac and renal tissue under specific conditions (hypoxia) (Sudo et al. 2009 ), the present results suggest that the nicorandil and its precursor molecule are not able to influence cell proliferation and death of cell 786-O under normal oxygenation. Its effects may be related to ischemia-reperfusion condition. However, the molecules can better be studied for their inhibitory effect on cell proliferation, since in our results there was a slight tendency to reduced cell proliferation, whereas in the case of the renal injuries, as well as in other studies of the control of cell growth disorder, the effect is very interesting considering the possible effect independent of NO.
